Theracare Pain Relieving Menthol Gel

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with sore muscles and joints. Specifically, it is effective for conditions such as arthritis, backache, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be cleaned prior to the application of the product. For adults and children aged 2 years and older, the product may be applied to the affected area up to 3 to 4 times daily. For children under 2 years of age, it is recommended to consult a physician before using this product.

Contraindications

The product is contraindicated in the following situations:

• Co-administration with other topical pain relievers is not recommended due to the potential for increased irritation or adverse effects.

• The use of heating pads or other heating devices concurrently is contraindicated, as this may enhance absorption and increase the risk of skin irritation.

• Contact with the eyes must be avoided to prevent irritation or injury.

• Tight bandaging of the application site is contraindicated, as it may lead to increased local irritation or adverse reactions.

• Application to wounds or damaged skin is not advised due to the risk of exacerbating the condition or causing further irritation.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to adhere strictly to the following precautions to ensure safe and effective use.

Usage Restrictions Patients should be instructed not to use this product in conjunction with other topical pain relievers, as this may increase the risk of adverse effects. Additionally, the application of heating pads or other heating devices while using this product is contraindicated, as it may exacerbate skin irritation or lead to burns. It is imperative to avoid contact with the eyes, and patients should be cautioned against applying the product to wounds or damaged skin. Bandaging should be done loosely, as tight bandages may impede circulation and exacerbate local irritation.

Monitoring and Consultation Patients must be advised to discontinue use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. This monitoring is essential to ensure that any underlying conditions are appropriately addressed.

Pregnancy and Breastfeeding For patients who are pregnant or breastfeeding, it is crucial to seek guidance from a healthcare professional prior to using this product to assess any potential risks.

Pediatric Considerations This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (800-222-1222) should be contacted without delay.

Side Effects

Patients should be aware that this product is for external use only. It is important to avoid using this product in conjunction with other topical pain relievers or heating devices, such as heating pads. Contact with the eyes should be strictly avoided, and the product should not be applied to wounds or damaged skin. Additionally, patients should refrain from bandaging the area tightly after application.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

For pregnant or breastfeeding individuals, it is recommended to seek guidance from a health professional prior to use.

This product should be kept out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately at 800-222-1222.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Theracare Pain Relieving Menthol Gel (menthol 2%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the product to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician prior to use.

Geriatric Use

There is no specific information regarding the use of TheraCare Pain Relieving Menthol Gel in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when administering this product to elderly patients, as the absence of data necessitates careful monitoring for any potential adverse effects or interactions. It is advisable to consider the overall health status and individual needs of geriatric patients when recommending this treatment.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the prescribing information regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children. Accidental ingestion can occur, and immediate action is required. Healthcare professionals should advise caregivers to seek medical assistance or contact a Poison Control Center at 800-222-1222 without delay.

Prompt intervention is crucial in managing potential overdosage situations. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and address any adverse effects that may arise.

Management procedures should include a thorough evaluation of the patient's condition, monitoring vital signs, and providing supportive care as necessary. It is essential to follow established protocols for the specific substance involved in the overdosage to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately at 800-222-1222.

Patients should be instructed to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using this product, it is important to inform patients that they should not use it in conjunction with other topical pain relievers. Additionally, patients should be cautioned against using heating pads or other heating devices while using this product. They should avoid contact with the eyes and should not bandage the area tightly. Furthermore, patients should be advised not to apply the product to wounds or damaged skin.

Storage and Handling

The product is supplied in a container that must be kept tightly closed when not in use to maintain its integrity. It should be stored at room temperature, ensuring that it is not exposed to freezing conditions. Additionally, it is crucial to avoid using, pouring, spilling, or storing the product near heat sources or open flames to prevent any potential hazards.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Theracare Pain Relieving Menthol Gel, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)